Author
University of Alabama at BirminghamORCID 0009-0007-5589-8144Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Charles Murchison, Giacomo Antonello, Zachary D. Wallen…·Haydeh Payami
This study identifies dysbiotic gut microbiome features in Parkinson's disease, links them to genetic variants, and proposes microbiome-based biomarkers for targeted treatment.
Shreya N. Kashyap, Stephanie N. Fox, Katherine I. Wilson…·Erik D. Roberson
Blocking the carboxy terminus of progranulin enhances gene therapy efficacy in progranulin-deficient mice by reducing sortilin interactions and improving biomarker outcomes.
Haydeh Payami, Timothy Robert Sampson, Charles Murchison, Zachary D. Wallen
The paper develops microbiome-based biomarkers to identify suitable patients for microbiome-based therapies in Parkinson's disease, showing that not all patients have dysbiotic microbiomes and that dysbiotic microbiomes vary in features.
Selda Yildiz, Miranda M. Lim, Manoj K. Sammi…·William D. Rooney
This paper measures brain lactate levels during sleep-wake cycles in humans using MRS and PSG, finding significant reductions during sleep stages compared to wakefulness.
Fabio Raman, Sameera Grandhi, Charles Murchison…·Alzheimer’s Disease Neuroimaging Initiative
BLAzER is a semi-automated workflow for regional brain PET quantification validated on ADNI data, showing strong agreement with ADNI and minimal discrepancies.